Harbor Investment Advisory’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $252K | Buy |
|
|||||
|
2025
Q2 | $49.8K | Sell |
|
|||||
|
2025
Q1 | $94.1K | Sell |
|
|||||
|
2024
Q4 | $490K | Sell |
|
|||||
|
2024
Q3 | $703K | Buy |
|
|||||
|
2024
Q2 | $653K | Sell |
|
|||||
|
2024
Q1 | $882K | Buy |
|
|||||
|
2023
Q4 | $205K | Buy |
|
|||||
|
2023
Q3 | $99.3K | Sell |
|
|||||
|
2023
Q2 | $257K | Sell |
|
|||||
|
2023
Q1 | $268K | Sell |
|
|||||
|
2022
Q4 | $316K | Sell |
|
|||||
|
2022
Q3 | $429K | Buy |
|
|||||
|
2022
Q2 | $308K | Buy |
|
|||||
|
2022
Q1 | $301K | Sell |
|
|||||
|
2021
Q4 | $381K | Buy |
|
|||||
|
2021
Q3 | $229K | Hold |
|
|||||
|
2021
Q2 | $246K | Sell |
|
|||||
|
2021
Q1 | $254K | Buy |
|
|||||
|
2020
Q4 | $255K | Buy |
|
|||||
|
2020
Q3 | $157K | Buy |
|
|||||
|
2020
Q2 | $113K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $5K | Buy |
|